Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Figures corrected NBB
Corrected annual account filed for 2024.
Financials
Financial year 2025
Kom op tegen Kanker from Sint-Joost-ten-Node, company number BE0442528054, closed financial year 2025 with a result of € -1.7 million after tax. For that financial year Kom op tegen Kanker recorded revenue of € 4 million and equity of € 43.9 million. Compared with financial year 2024, the result moved from € -141,358 to € -1.7 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 14, 2026.
€ 43.9 million
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.7 million
▼ 1090 % more loss than in 2024
Profit after tax over the fiscal year.
€ 13.5 million
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
93.1
▲ 2.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 9.8 million
▲ 5% vs 2024
€ 105,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,400
▼ 65% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 17.3 million
▲ 1% vs 2024
Loans from banks and other lenders, long and short.
€ 1.6 million
▼ 13% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 41 days on average.
€ 1.5 million
▲ 2% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 2,402,665 | € 3,684,691 | € 3,564,401 | € 4,005,168 | ▲ 12% |
| Profit after taxes | € 5,290,375 | € 6,430,584 | € -141,358 | € -1,681,882 | ▼ € 1.5 million |
| Equity | € 39,341,256 | € 45,771,839 | € 45,630,481 | € 43,948,599 | ▼ 4% |
| Total debts | € 39,084,635 | € 43,979,423 | € 54,028,937 | € 60,524,547 | ▲ 12% |
| Cash | € 17,591,299 | € 9,391,495 | € 12,132,402 | € 13,503,796 | ▲ 11% |
| Land & buildings | € 1,975,074 | € 1,892,314 | € 1,781,436 | € 1,670,585 | ▼ 6% |
| Retained profit | € 38,696,785 | € 45,127,368 | € 44,986,010 | € 43,304,128 | ▼ 4% |
| Bank debt | € 12,999,476 | € 12,218,211 | € 17,022,021 | € 17,261,948 | ▲ 1% |
| Balance sheet total | € 78,425,891 | € 89,751,262 | € 99,659,418 | € 104,473,146 | ▲ 5% |
| Employees (FTE) | 83.1 | 84.7 | 90.3 | 93.1 | ▲ 2.8 |
Key figures of Kom op tegen Kanker, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Kom op tegen Kanker?
What happened at Kom op tegen Kanker in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Marion Debruyne stepped down as director. NBB
- Geert Van Boxem stepped down as director. NBB
- Najat El Aissati stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.7 million. Source: NBB ↗
- Ann Demeulemeester stepped down as director. NBB
- Sabien Bauwens stepped down as director. NBB
- Tessa Kerre stepped down as director. NBB
- Sara Willems stepped down as director. NBB
In short
From € 5.3 million profit in 2022 to € 1.7 million loss in 2025.
Best year ever: 2023, with € 6.4 million profit.
Pays suppliers within 41 days on average.
A new publication or filing at Kom op tegen Kanker? We notify you, reason included.
Follow Kom op tegen KankerDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Kom op tegen Kanker is David Vansteenbrugge. David Vansteenbrugge is also behind Kom op tegen Kanker.
Directors
According to the 2025 annual accounts
since 2023
Ann Demeulemeester
Director
Also active at: Odisee, Familiehulp, Emmaüs, HUB-KUBrussel, Wereldsolidariteit, Familiehulp kinderopvang De Speelboom, Alzheimer Liga Vlaanderen, Vereniging voor Social-Profit Ondernemingen +2 more
since 2025 · until 2026
since 2023 · until 2026
Sabien Bauwens
Director
Also active at: Palliatief Netwerk Omega, Netwerk Palliatieve Zorg Brussel-Halle-Vilvoorde, Kom op tegen Kanker
since 2025 · until 2026
Jan Hautekiet
Director
Also active at: ROSAS, be.brusseleir, Vlaams -Nederlands huis deBuren, Kom op tegen Kanker
since 2019 · until 2026
Dirk Verellen
Director
Also active at: EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY, Kom op tegen Kanker
since 2017 · until 2026
Tessa Kerre
Director
Also active at: DE VRIENDEN VAN HET MUSEUM VOOR SCHONE KUNSTEN GENT, WAHWAH, Kom op tegen Kanker
since 2025 · until 2026
Rik Duyck
Penningmeester, Director
Also active at: Touring Club Royal de Belgique - Koninklijke Belgische Touring Club - Köninglicher Belgischer Touring Club - Royal Touring Club Belgium - T.C.B., BELGISCH WERK TEGEN KANKER, TCRB Holding, Kom op tegen Kanker
since 2014 · until 2026
since 2018 · until 2026
since 2017 · until 2026
since 2022 · until 2025
since 2023 · until 2026
since 2015 · until 2025
since 2023 · until 2026
since 2017 · until 2026
Jacques De Grève
Vice-chairman of the board, Chairman of the board, Director
since 2006 · until 2026
since 2022 · until 2026
since 2010 · until 2026
since 2024 · until 2026
since 2023 · until 2026
since 2022 · until 2026
since 2009 · until 2026
Marc Michils
Chairman of the board, Director, Algemeen Directeur
Also active at: Familiehulp, Familiehulp kinderopvang De Speelboom, Michils - Vandenberghe Company, Kinderdagverblijf Mezennestje, BELGISCH WERK TEGEN KANKER, Vlaams-Brusselse Media, Envia Waas, Itinera Institute +1 more
since 2012 · until 2026
since 2025 · until 2026
since 2008 · until 2026
Establishments
Establishment units
Physical locations of this company
Koningsstraat 217
1210 Sint-Joost-ten-Node
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
LEVEL27-AS * Please direct all complaints to [email protected] *, BE
Website info
Features
Security
Network
Details
- Company number
- 0442.528.054
- VAT number
- BE 0442.528.054
- Registered office
- Koningsstraat 217, 1210 Sint-Joost-ten-Node
- Names & denominations
- Kom op tegen Kanker · KotK
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 3 October 1989
- Peppol
- Active · Active since 11 Sept 2025
- Contact
- komoptegenkanker.be
- Activities · NACE
Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering